Home
Productsindex
Gene
mRNA Productsindex
mRNAs for Vaccine Developmentlists
ZEBOV(strain Mayinga-76)  VP35 Protein Circular RNA
VAC-RNA-080
ZEBOV(strain Mayinga-76) VP35 Protein Circular RNA
Source:In vitro transcribed mRNA was further circularized to make this product as a circular RNA.
Alternative Names:Polymerase cofactor VP35 (Ebola VP35) (eVP35)
SKU:VAC-RNA-080-LNP
Product Name:ZEBOV(strain Mayinga-76) VP35 Protein Circular RNA-LNP
Product Description:VAC-RNA-080 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
SKU:VAC-RNA-080
Product Name:ZEBOV(strain Mayinga-76) VP35 Protein Circular RNA
Product Description:In Vitro Transcribed mRNA template encoding ZEBOV(strain Mayinga-76) VP35 Protein Circular RNAwas further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
SKU:VAC-RNA-080-LNP
Product Name:ZEBOV(strain Mayinga-76) VP35 Protein Circular RNA-LNP
Product Description:VAC-RNA-080 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
SKU:VAC-RNA-080
Product Name:ZEBOV(strain Mayinga-76) VP35 Protein Circular RNA
Product Description:In Vitro Transcribed mRNA template encoding ZEBOV(strain Mayinga-76) VP35 Protein Circular RNAwas further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
PROPERTIES
ORF:
=A81
Modifications:
N1-methyl-pseudouridine
Neutral Lipid:
1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC)
Cholesterol:
Cholesterol
Lonizable Lipid:
1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 (PEG2000-DMG)
PEG-lipid:
Heptadecan-9-yl 8-((2-hydroxyethyl)(8-(nonyloxy)− 8-oxooctyl)amino)octanoate)(SM-102)
Storage:
-80 °C
Buffer:
PBS, pH7.83
Cryoprotectant:
Trehalose
Related Categories
mRNAs for Vaccine Development
Background

Gene Accession

Q05127

Gene Alias

Polymerase cofactor VP35 (Ebola VP35) (eVP35)

Background

FUNCTION: Plays an essential role in viral RNA synthesis and also a role in suppressing innate immune signaling (PubMed:11027311). Acts as a polymerase cofactor in the RNA polymerase transcription and replication complexes (PubMed:9971816, PubMed:16495261, PubMed:24495995). Serves as nucleoprotein/NP monomer chaperone prior to the formation of the large oligomeric RNA-bound complexes (By similarity). Regulates RNA synthesis by modulating NP-RNA interactions and interacting with DYNLL1 (PubMed:25741013). VP35-NP interaction controls the switch between RNA-bound NP and free NP and thus the switch between genome replication and genome packaging into the nucleocapsid (PubMed:25865894). Prevents establishment of cellular antiviral state, thereby suppressing host DC maturation (PubMed:26962215). Acts by inhibiting host RIGI activation both by shielding dsRNA from detection and by preventing PRKRA binding to RIGI (PubMed:23870315). Blocks virus-induced phosphorylation and activation of interferon regulatory factor 3/IRF3, a transcription factor critical for the induction of interferons alpha and beta (PubMed:12829834). This blockage is produced through the interaction with and inhibition of host IKBKE and TBK1, producing a strong inhibition of the phosphorylation and activation of IRF3 (PubMed:12829834). Also inhibits the antiviral effect mediated by the host interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2/PKR (PubMed:17065211). Increases PIAS1-mediated SUMOylation of IRF7, thereby repressing interferon transcription (PubMed:19557165). Also acts as a suppressor of RNA silencing by interacting with host DICER1, TARBP2/TRBP and PRKRA/PACT (By similarity). As a dimer, binds and sequesters dsRNA contributing to the inhibition of interferon production (By similarity). {ECO:0000250|UniProtKB:Q5XX07, ECO:0000250|UniProtKB:Q6V1Q9, ECO:0000250|UniProtKB:Q8JPY0, ECO:0000269|PubMed:11027311, ECO:0000269|PubMed:12829834, ECO:0000269|PubMed:16495261, ECO:0000269|PubMed:17065211, ECO:0000269|PubMed:19557165, ECO:0000269|PubMed:23870315, ECO:0000269|PubMed:24495995, ECO:0000269|PubMed:25741013, ECO:0000269|PubMed:25865894, ECO:0000269|PubMed:26962215, ECO:0000269|PubMed:9971816}.

RECOMMENDED PRODUCTS
BioActive Human ABL1 (V299L,T315A,F317L,F317V,F317I,F317C) Recombinant Protein,Fc Tag
ABL1

SGRP00624

BioActive Human ABL1 (V299L,T315A,F317L,F317V,F317I,F317C) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human ABL1 (T315A,F317L,F317V,F317I,F317C,V299L) Recombinant Protein,Fc Tag
ABL1

SGRP00628

BioActive Human ABL1 (T315A,F317L,F317V,F317I,F317C,V299L) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human AKT1 (Q79K,E17K) Recombinant Protein,Fc Tag
AKT1

SGRP00630

BioActive Human AKT1 (Q79K,E17K) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human AKT1 (H238Y) Recombinant Protein,Fc Tag
AKT1

SGRP00631

BioActive Human AKT1 (H238Y) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human ALK (G1123S) Recombinant Protein,Fc Tag
ALK

SGRP00637

BioActive Human ALK (G1123S) Recombinant Protein,Fc Tag
View Price and Availability
0.120615s